Ortec International
This article was originally published in The Gray Sheet
Executive Summary
Initiates 120-patient, six-center trial of its Composite Cultured Skin for the treatment of "full and deep partial thickness burns," with the first patient enrolled March 16 at the Cornell New York Hospital Burn Center, New York City. The Composite Cultured Skin is "a biologically active dressing composed of a biodegradable matrix seeded with epidermal and dermal cells derived from infant foreskins" and "induces the rapid regeneration of healthy skin with minimal scarring and without the need for autografts," according to the Glendale, New York-based private firm